Royalty Pharma $1.3 billion senior notes offering
We advised Royalty Pharma on its SEC-registered investment-grade notes offering, including $600 million in social bonds
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Black Spade Acquisition $150 million IPO
We advised Black Spade, a SPAC, on its IPO and NYSE listing
Gobi Acquisition $250 million IPO
We advised the joint book-running managers on the SPAC IPO and Nasdaq listing
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Mizuho Financial Group $1.75 billion senior notes offering
The offering involved senior callable fixed-to-fixed reset rate notes due 2027 and 2032
Cellnex Telecom $600 million senior notes offering
We advised Cellnex on its offering of senior notes due 2041
Frontier Investment $200 million IPO
We advised the underwriter on the SPAC IPO and Nasdaq listing
China Oil and Gas Group $400 million senior notes offering
We advised the joint global coordinators on the Regulation S offering
Magnum Opus Acquisition $200 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing